BENUSSI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 6.365
AS - Asia 3.764
EU - Europa 2.743
SA - Sud America 793
AF - Africa 85
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.767
Nazione #
US - Stati Uniti d'America 6.220
SG - Singapore 1.431
CN - Cina 1.103
BR - Brasile 687
IT - Italia 662
HK - Hong Kong 526
DE - Germania 504
UA - Ucraina 365
GB - Regno Unito 267
FI - Finlandia 239
VN - Vietnam 210
RU - Federazione Russa 191
TR - Turchia 151
IE - Irlanda 132
FR - Francia 101
IN - India 79
CA - Canada 71
BD - Bangladesh 62
MX - Messico 52
AR - Argentina 47
CZ - Repubblica Ceca 43
NL - Olanda 43
ZA - Sudafrica 43
PL - Polonia 41
BE - Belgio 38
SE - Svezia 31
IQ - Iraq 30
JP - Giappone 25
AT - Austria 23
ES - Italia 22
SA - Arabia Saudita 18
PK - Pakistan 16
UZ - Uzbekistan 15
ID - Indonesia 14
PY - Paraguay 12
EC - Ecuador 11
MA - Marocco 11
CO - Colombia 10
IL - Israele 10
TW - Taiwan 10
AU - Australia 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
JO - Giordania 8
LT - Lituania 8
UY - Uruguay 8
NP - Nepal 7
VE - Venezuela 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
EG - Egitto 5
IR - Iran 5
RO - Romania 5
TN - Tunisia 5
BH - Bahrain 4
BY - Bielorussia 4
CL - Cile 4
DZ - Algeria 4
EU - Europa 4
KE - Kenya 4
KG - Kirghizistan 4
PH - Filippine 4
BG - Bulgaria 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
EE - Estonia 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
OM - Oman 3
PE - Perù 3
SN - Senegal 3
CH - Svizzera 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
KR - Corea 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AW - Aruba 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
KW - Kuwait 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
SC - Seychelles 1
SI - Slovenia 1
SL - Sierra Leone 1
Totale 13.765
Città #
Fairfield 699
Singapore 638
Ashburn 555
Hong Kong 522
Woodbridge 384
Chandler 318
Beijing 305
Jacksonville 295
New York 280
Seattle 254
Wilmington 253
Houston 250
Cambridge 249
Ann Arbor 227
Princeton 200
Los Angeles 172
Helsinki 165
Munich 153
Dublin 132
Istanbul 124
Dallas 102
Milan 99
Brescia 96
The Dalles 92
São Paulo 85
Nanjing 82
Ho Chi Minh City 80
Dearborn 75
Redondo Beach 68
Des Moines 67
Shanghai 64
Moscow 60
San Francisco 60
Turku 60
Chicago 51
Buffalo 49
London 43
Hanoi 41
Jinan 40
Brussels 38
Boardman 37
Nanchang 36
San Diego 36
Santa Clara 36
Warsaw 35
Nuremberg 34
Hebei 33
Changsha 31
Olomouc 30
Denver 29
Shenyang 29
Phoenix 27
Johannesburg 26
Montreal 24
Brooklyn 23
Rome 23
Tokyo 21
Atlanta 20
Belo Horizonte 20
Charlotte 20
Lancaster 20
Guangzhou 19
Mexico City 18
Toronto 18
Chennai 17
Mumbai 17
Rio de Janeiro 17
Stockholm 17
Boston 16
Frankfurt am Main 16
Tianjin 16
Hangzhou 15
Manchester 15
Norwalk 15
San Mateo 15
Kunming 14
Ningbo 14
Vienna 14
Augusta 13
Dhaka 13
Jiaxing 13
Poplar 13
Tashkent 13
Amsterdam 12
Brno 12
Romola 12
Taizhou 12
Düsseldorf 11
Kocaeli 11
Washington 11
Baghdad 9
Erbil 9
Riyadh 9
Taipei 9
Taiyuan 9
Trieste 9
Zhengzhou 9
Amman 8
Betim 8
Bologna 8
Totale 8.623
Nome #
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 215
COVID-19 impact on consecutive neurological patients admitted to the emergency department 209
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 202
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 195
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 189
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 188
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 172
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 165
Autoimmunity and frontotemporal dementia 165
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 161
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 161
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 155
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 152
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 152
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 152
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 152
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 152
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 149
Natural history and predictors of survival in progressive supranuclear palsy. 139
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 138
Multimodal Brain Analysis of Functional Neurological Disorders: A Functional Stroke Mimic Case Series. 136
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. 134
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. 134
Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. 134
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. 134
Author response: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 134
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. 132
Modulating risky decision-making in Parkinson's disease by transcranial direct current stimulation. 131
Clinical, genetic, and neuroimaging features of Early Onset Alzheimer Disease: the challenges of diagnosis and treatment. 130
Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C. 130
The impact of TMS on the differential diagnosis and progression of dementia 130
Method of generation of a diagnostic index for Alzheimer disease, electronic apparatus for implementation of the method and system 127
Serum neurofilament light in professional soccer players: goal on safety 124
Facial feedback and autonomic responsiveness reflect impaired emotional processing in Parkinson's Disease. 123
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 123
Embedded platform-based system for early detection of Alzheimer disease through transcranial magnetic stimulation 122
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. 119
Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC 119
TMS for staging and predicting functional decline in frontotemporal dementia 119
Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38 118
Modulation of long-term potentiation-like cortical plasticity in the healthy brain with low frequency-pulsed electromagnetic fields 116
Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 116
Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study 116
Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia. 115
Toward a Glutamate Hypothesis of Frontotemporal Dementia 114
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 113
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy. 112
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia. 112
Clinical and neurophysiological characteristics of heterozygous NPC1 carriers 112
New insights into the genetic etiology of Alzheimer’s disease and related dementias 111
Variability and predictors of response to continuous theta burst stimulation: A TMS-EEG study 111
Mild cognitive impairment in Parkinson's disease is improved by transcranial direct current stimulation combined with physical therapy. 110
Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial 108
Classification accuracy of TMS for the diagnosis of mild cognitive impairment 107
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: Impact on diagnostic confidence and diagnostic accuracy 106
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 105
CSF p-Tau181/Tau ratio to distinguish FTLD-TDP from FTLD-Tau 104
Transcranial Magnetic Stimulation in Alzheimer's Disease and Cortical Dementias 103
Cortical Inhibitory Imbalance in Functional Paralysis 103
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 103
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 102
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 99
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 98
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 98
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 97
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 96
Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study 94
CSF p-Tau181/Tau ratio as biomarker for TDP pathology in Frontotemporal Dementia 93
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 93
Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias 92
Neurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia 92
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 91
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 89
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 89
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 89
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 88
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study 86
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 86
Clinical and radiological features of posterior cortical atrophy (PCA) in a GRN mutation carrier: a case report 84
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 83
Prevalence of cerebrospinal fluid Alzheimer disease-like pattern in atypical dementias 82
Transcranial stimulation in frontotemporal dementia: A randomized, double-blind, sham-controlled trial 82
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 82
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 82
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study 81
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 79
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 77
Recent advances in understanding frontotemporal degeneration 76
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration 76
Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single-center cohort study 74
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 73
The role of transcranial magnetic stimulation in the diagnosis of dementia 72
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 71
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 71
Differential early subcortical involvement in genetic FTD within the GENFI cohort 71
A novel CSF1R mutation mimicking frontotemporal dementia: A glimpse into a microgliopathy 70
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 69
Voluntary inhibitory control and impulsivity in Parkinson’s disease patients with and without levodopa-induced dyskinesias 68
Prodromal frontotemporal dementia: clinical features and predictors of progression 67
Citicoline Treatment in Acute Ischemic Stroke: A Randomized, Single-Blind TMS Study 64
Totale 11.439
Categoria #
all - tutte 80.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021911 0 0 0 0 0 127 66 149 126 204 176 63
2021/2022861 61 71 27 34 10 52 86 82 55 97 100 186
2022/20231.071 121 65 48 71 76 244 24 89 148 55 65 65
2023/20241.216 78 32 148 72 37 239 32 55 248 35 35 205
2024/20253.193 46 19 25 519 283 253 235 125 422 305 560 401
2025/20263.495 621 790 483 916 624 61 0 0 0 0 0 0
Totale 14.012